Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HEPLISAV-B Booster in Hemodialysis Patients
NCT01195246Phase 3Completed
- Sponsor
- Dynavax Technologies
- Start
- Dec 2010
- Primary completion
- Feb 2012
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of Heplisav-B in hepatitis B (HBV), sponsored by Dynavax Technologies. Started Dec 2010; status: completed.
02
Drugs
Heplisav-B
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT01195246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01195246.